The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit. South African variant can ‘break through’ Pfizer vaccine, Israeli study says
By Maayan Lubell JERUSALEM (Reuters) – The coronavirus variant discovered...
0
